(redirected from Oncologic Drugs Advisory Committee)
Category filter:
ODACOld Dominion Athletic Conference
ODACOracle Data Access Components
ODACOil Depletion Analysis Centre
ODACOncologic Drugs Advisory Committee
ODACOutdoor Adventure Club
ODACOpen Democracy Advice Centre
ODACOntarians with Disabilities Act Committee (Canada)
ODACOffice of Development Approvals Coordination (Australia)
ODACOrgan Donor Awareness Campaign
ODACOpen Document Architecture Consortium
ODACOld Dominion Aquatic Club
ODACOffice Départemental d'Animation Culturelle (France)
ODACOrgan Donation Advisory Committee (Pennsylvania)
ODACOnline Divisive-Agglomerative Clustering
ODACOpen Distributed Applications Construction
ODACOrganisational Development for Advisors and Consultants
ODACOkinawa District Advisory Council
ODACOnline Digital Advertising Connection
ODACOrgan Donation Awareness Council (Indiana)
ODACOregon Dealer Advisory Committee
ODACOn-line Disk Arms Calculator (IBM)
ODACOlathe District Activites Complex (Kansas)
ODACOlder Driver Advisory Committee (Oregon)
ODACOntmoetings-en Dagactiviteitencentra
ODACOn-Board Data Acquisition and Control
ODACOperation Display and Control
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
That's right; although the members of FDA's Oncologic Drugs Advisory Committee are required to disclose any conflicts of interest, presenters who defended women's right to choose an ineffective and expensive drug didn't have to disclose that they--or the organizations they represent were paid by the company that makes the ineffective and expensive drug.
The regulator's Oncologic Drugs Advisory Committee voted unanimously recommending approval of the product, a proposed monoclonal antibody biosimilar to Rituxan intended to treat adult patients in three proposed indications.
That was demonstrated through a number of developments: The FDA accepted the first biosimilar applications; the regulatory agency published the all-new "purple book," listing biologic drug patents, exclusivities and future interchangeable products; the nation witnessed the first-ever appel late court case involving a biosimilar application; and the FDA's oncologic drugs advisory committee voted unanimously to recommend the approval of filgrastim.
The Oncologic Drugs Advisory Committee agreed with the agency that a validated test for the Bcr-Abl T3151 mutation is required before omacetaxine mepesuccinate (Omapro)--a drug targeting that mutation--can be considered for approval.
GlaxoSmithKline, Philadelphia, PA, announced the FDA's Oncologic Drugs Advisory Committee (ODAC) has voted unanimously for pazopanib (Votrient) for treating patients with advanced renal cell carcinoma (RCC) despite concerns bout a risk of severe liver injury.
In July the FDA's Oncologic Drugs Advisory Committee voted 10:4 to recommend the drug's use for postmenopausal women at high risk for breast cancer, and voted 8:6 for its use in postmenopausal women with osteoporosis.
These data were presented by Berlex at an FDA Oncologic Drugs Advisory Committee meeting earlier this year.
Food and Drug Administration (FDA) oncologic drugs advisory committee recommended that the agency withhold approval for NCI's new tamoxifen study.
Shares of Karyopharm are moving sharply lower after the FDA posted briefing documents for the Oncologic Drugs Advisory Committee Meeting planned for February 26 to review the New Drug Application for Selinexor.
In late May, an Oncologic Drugs Advisory Committee (ODAC) voted to recommend approval of the proposed biosimilar.